An Analysis of the Distribution of Direct Cost of Diabetes Care in Selected Districts in Italy

ConclusionAnnual cost of treatment for people with diabetes is similar for those treated with MDI or with basal insulin only, with hospitalization being the main cost driver. This indicates that both patient groups should benefit from having access to scanning continuous glucose monitoring (CGM) technology which is known to be associated with significantly reduced hospitalization for acute diabetes events, compared to self-monitored blood glucose (SMBG) testing.
Source: Diabetes Therapy - Category: Endocrinology Source Type: research